[go: up one dir, main page]

Eggers et al., 2010 - Google Patents

Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in Germany

Eggers et al., 2010

View HTML @Full View
Document ID
5399060861916411488
Author
Eggers M
Terletskaia-Ladwig E
Rabenau H
Doerr H
Diedrich S
Enders G
Enders M
Publication year
Publication venue
BMC infectious diseases

External Links

Snippet

Abstract Background In October 2007, the working group CEN/TC 216 of the European Committee for standardisation suggested that the Sabin oral poliovirus vaccine type 1 strain (LSc-2ab) presently used for virucidal tests should be replaced by another attenuated …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Similar Documents

Publication Publication Date Title
Tiberghien et al. Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how?
Haddock et al. A cynomolgus macaque model for Crimean–Congo haemorrhagic fever
Strebel et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease
Chan et al. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study
Burr et al. Poliomyelitis prevention in the United States; updated recommendations of the Advisory Committee on Immunization Practices (ACIP)
Mani et al. Utility of real‐time Taqman PCR for antemortem and postmortem diagnosis of human rabies
Ludi et al. Serotype diversity of foot‐and‐mouth‐disease virus in livestock without history of vaccination in the far north region of Cameroon
Hemida et al. Coronavirus infections in horses in Saudi Arabia and Oman
Rubin et al. Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans
Kasloff et al. Pathogenicity of Nipah henipavirus Bangladesh in a swine host
Thompson et al. Seroepidemiology of selected alphaviruses and flaviviruses in bats in Trinidad
Santos et al. Should we be concerned about COVID‐19 with nonhuman primates?
Abbink et al. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion
Xia et al. Neutralization of Omicron SARS-CoV-2 by 2 or 3 doses of BNT162b2 vaccine
Luo et al. Isolation and characterization of encephalomyocarditis virus from dogs in China
Norrby et al. Polio and Nobel prizes: looking back 50 years
Utsumi et al. Prevalence of hepatitis E virus among swine and humans in two different ethnic communities in Indonesia
Coertse et al. Comparative neutralization activity of commercial rabies immunoglobulin against diverse lyssaviruses
Černáková et al. Isolation of vaccine-derived polioviruses in the Slovak Republic
Srikanth et al. Evaluation of safety and potency of Kyasanur Forest Disease (KFD) vaccine inactivated with different concentrations of formalin and comparative evaluation of in vitro and in vivo methods of virus titration in KFD vaccine
Eggers et al. Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in Germany
Fumagalli et al. Protective immunity against Gamma and Zeta variants after inactivated SARS-CoV-2 virus immunization
Yadav et al. SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model
Lamb COVID-19 diagnostic testing: Lessons learned for innovative product development during a public health emergency
Minor et al. Natural infection and transmission of SV40